Traditional control experiments to demonstrate the target specificity of antibody-based probes do not apply to in vivo PD-L1 quantification studies since a blocking dose of cold antibody saturates the PD-L1 receptors in the host immune system, which may lead to a high tumor uptake of the imaging probe (26). The gene discussed is CD274; the disease is neoplasm.